85622-93-1
MOSINTER
85622-93-1
Availability: | |
---|---|
Payment & Shipping Terms | Supply Capacity | ||
Payment Terms: | T/T, WU | Production Capacity: | 1000kg/year |
Min. Order: | 1 Gram | Packing: | according to the customer's requirements |
Means of Transport: | Ocean, Air, Land | Delivery Date: | 7 days |
Temozolomide
CAS 85622-93-1
Temozolomide is the first oral effective imidazolium tetrazine anti-tumor drug, which belongs to the second generation of alkylating agents with anti-tumor activity. After oral administration, temozolomide does not need to be activated by metabolism in the liver. It is easy to pass through the blood-brain barrier, has good tolerance and no superimposed toxicity with other drugs. It has synergistic effect with radiotherapy, and is suitable for recurrent malignant glioma after conventional treatment, such as polymorphous gum It is also the first-line treatment for metastatic melanoma.
We can customize according to customer's requirement
if you have any question pls mail us or call us.